Bioceres Crop Solutions Corp. (BIOX) stock
BIOXNasdaqAgricultural ChemicalsFiscal year ends June 30
$0.20−0.01 (-4.90%)
Close on Nov 16, 2026Market cap $12.74MP/E –Yield –
Bioceres Crop Solutions revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Bioceres Crop Solutions's revenue for the twelve months ending Dec 31, 2025 was $240.86M, down 32.3% year over year. For fiscal 2026 it was $238.28M, down 17.7% from the year before. The highest annual figure on record is $420.39M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $238.28M | -17.7% |
| FY2025 | Jun 30, 2025 | $289.43M | -31.2% |
| FY2024 | Jun 30, 2024 | $420.39M | +0.1% |
| FY2023 | Jun 30, 2023 | $420.06M | +25.4% |
| FY2022 | Jun 30, 2022 | $334.84M | +59.8% |
| FY2021 | Jun 30, 2021 | $209.53M | +21.0% |
| FY2020 | Jun 30, 2020 | $173.09M | +7.8% |
| FY2019 | Jun 30, 2019 | $160.61M | +290.1% |
| FY2016 | Dec 31, 2016 | $41.17M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $73.81M | -25.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $77.60M | -16.8% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $28.87M | -63.7% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $60.59M | -27.9% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $98.80M | -29.5% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $93.29M | -20.0% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $79.60M | -24.0% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $83.98M | -9.7% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $140.22M | +48.3% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $116.59M | -8.4% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $104.71M | -1.0% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $92.98M | +33.8% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $94.55M | +2.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $127.33M | +161.3% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $105.79M | +67.9% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $69.48M | +11.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $92.66M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $48.74M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $62.99M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $62.45M | – |
See a number that looks wrong?